Where is weed legal?
Europe could follow American example as more states legalise cannabis
A vote on whether cannabis, or weed, should be legalised in Italy could take place as early as next year.
It would be the first European nation to make the move, after a public petition gained 500,000 signatures, the amount needed for a national referendum to be held on the issue. “If Italy crosses the sticky weedline, European neighbours will also follow,” reported Reuters.
And on the other side of the Atlantic, New York lawmakers have approved a bill that will allow individuals to carry up to 85 grams of cannabis on their person. It is hoped that the change in legislation will “put an end” to the disproportionate number of arrests of Black and Hispanic people in the state compared to white people, The New York Times reported.
So where, and under what circumstances, is weed already legal?
Although there are varying levels of toleration of personal use of the drug, no EU country has legalised cannabis so far, says the European Monitoring Centre for Drugs and Drug Addiction.
In ten EU nations, weed remains illegal but the law does not allow imprisonment for possession of small quantities of cannabis for personal use only. Those countries are:
- Czech Republic
Holland’s famous “cannabis cafes” are not strictly legal – authorities simply tolerate unlawful acts taking place inside as long as certain conditions are adhered to. The Dutch government says that in most cases where a person is found to have a small amount on their person, or to be growing less than five cannabis plants at home, it is unlikely to lead to prosecution.
Portugal could also be a likely contender to legalise marijuana in the near future. In 2000, the country decriminalised all illicit drugs in an attempt to get to grips with a national heroin crisis. People found using or possessing small quantities of such drugs are sent by police to a “dissuasion commission”, and they may then be fined.
Looking beyond Europe, several countries as well as American states have legalised cannabis in the past ten years. Uruguay was the first, in 2013. However some pharmacists encountered a “serious hiccup”, as partnerships with US banks “came under threat”, due to the US’s laws on controlled substances, the BBC reported.
Canada also legalised the drug in October 2018, but the “black market is still vibrant”, The Guardian reported. Retailers have struggled to meet demand, and the quality of the substances on sale is not as high as that from underground sellers, the newspaper continued. Higher prices have also pushed buyers away from legal routes.
The recreational use of marijuana has now been legalised, or is in the process of being legalised, in 18 American states, as well as Washington DC. They are:
- New Jersey
- New Mexico
- New York
California legalised marijuana for medical use two decades ago, but no EU nation has followed suit as yet. While smoking cannabis remains illegal in many EU member states, Sativex, a cannabis extract also known as nabiximols, is an authorised medicine in many, as well as the UK. Prescribing medical cannabis in the UK became legal in 2018, with three CBD-derived treatments now licensed for use on the NHS.
In a study on the use of medical cannabis for chronic pain published in the British Medical Journal this year, researchers found evidence that the drug led to improved pain relief, physical functioning and sleep quality in patients. However, at present medical cannabis is only available “for three rare types of childhood epilepsy, the vomiting and nausea associated with chemotherapy and multiple sclerosis-related spasticity”, The Guardian explained.
Other European countries that permit the use of cannabis, or cannabis-derived drugs, for medical reasons include:
- Czech Republic
- Denmark (not yet law, prescription permitted under an extended medical trial)
- Estonia (with a permit)
- San Marino
Beyond Europe, the medical use of the drug is permitted in New Zealand and Australia, as well as Jamaica, Barbados, Bermuda, Canada, Chile, Colombia, Ecuador, Israel, Lebanon, Malawi and Mexico, Morocco, Peru, Rwanda, St Vincent, South Africa, Sri Lanka, Thailand, Uruguay, Vanuatu, Zambia and Zimbabwe.
In 2017, Lesotho became the first African nation to legalise the growing of medical cannabis. Though recreational use or possession of the drug remains illegal, a medical cannabis producer, MG Health, was granted a licence earlier this year to begin exporting to the EU. “The company is optimistic accreditation will open doors to business with more EU countries and other international markets”, The Guardian reported, bringing significant employment opportunities to the “tiny mountain kingdom”.
Greece has similarly looked at medical cannabis for economic opportunities, seeing the potential financial benefits of legalising marijuana as a partial solution to its economic crisis.
In 2017, then prime minister Alexis Tsipras said he was bringing forward legislation allowing the drug’s use for medical purposes. His successor, Kyriakos Mitsotakis, swiftly granted new licences for growing medical marijuana. The government hope the export business will bring “around €360 million of investment and create up to 2,250 jobs”, reported consultancy firm Prohibition Partners.
According to The Independent, Tsipras said: “From now on, the country is turning its page, as Greece is now included in countries where the delivery of medical cannabis to patients in need is legal.”
Bloomberg reported in November 2017 that the Greek government hoped to put the legislation before parliament by the end of the year, although it has yet to materialise.
The then agriculture minister, Evangelos Apostolou, said growers had already expressed an interest in investing €1.5bn (£1.3bn) into projects to build greenhouse parks for cannabis production in Greece.
However, while many commentators had speculated that smoking weed would be legalised for medical purposes, Apostolou seemed to imply the new laws relate only to Sativex. He said: “Thousands of Greek households with family members suffering from serious illnesses like cancer and Parkinson’s disease will be able to get drugs produced right here, under World Health Organization guidelines.”